Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

       
Total article views   HTML views PDF downloads Totals
12,449 Dovepress* 10,696+ 2,072 12,768
PubMed Central* 1,753 563 2,316
Totals 12,449 2,635 15,084
*Since 17 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar